Skip to main content
Oxidative Medicine and Cellular Longevity logoLink to Oxidative Medicine and Cellular Longevity
. 2025 Oct 21;2025:9781730. doi: 10.1155/omcl/9781730

Correction to “Continuous Infusion of Angiotensin IV Protects against Acute Myocardial Infarction via the Inhibition of Inflammation and Autophagy”

PMCID: PMC12567313  PMID: 41169403

W. Bai, H. Wang, C. Gao, et al., “Continuous Infusion of Angiotensin IV Protects against Acute Myocardial Infarction via the Inhibition of Inflammation and Autophagy,” Oxidative Medicine and Cellular Longevity 2021 (2021): 2860488, https://doi.org/10.1155/2021/2860488.

In the article titled, “Continuous Infusion of Angiotensin IV Protects against Acute Myocardial Infarction via the Inhibition of Inflammation and Autophagy,” there was an error in Figure 1a. In Figure 1 legend, Ang IV and MI were attributed to the wrong color. The corrected figure is shown below and is listed as Figure 1:

Figure 1.

Figure 1

Ang IV increased survive rate after MI without any effect on lipid levels. (a) MI induced high mortality in mice, while Ang IV increased the survive rate after MI. (b) There was no significant differences in lipid levels in four groups of mice. Ang, angiotensin; D, days; HDL, high-density lipoprotein cholesterol; LDL, low-density lipoprotein cholesterol; MI, myocardial infarction; TC, total cholesterol; TG, triglycerides. p < 0.05.

We apologize for this error.


Articles from Oxidative Medicine and Cellular Longevity are provided here courtesy of Wiley

RESOURCES